Feedback / Questions
Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL
https://www.mdsabstracts.org/abstract/opicapone-improves-end-of-dose-neuropsychiatric-fluctuations-in-patients-with-parkinsons-disease/
R. de Fiores; I. Martino; A. Quattrone; B. Vescio; G. Arabia; A. Gambardella; M. Morelli
Oct 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next